Efficacy and safety of combination therapy with vildagliptin and nateglinide in type 2 diabetes.

Trial Profile

Efficacy and safety of combination therapy with vildagliptin and nateglinide in type 2 diabetes.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jun 2013

At a glance

  • Drugs Vildagliptin (Primary) ; Nateglinide
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Oct 2012 Novartis Pharma KK added as study supporter
    • 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
    • 02 Jun 2012 Status changed from active, no longer recruiting to completed University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top